SELEGILINE HYDROCHLORIDE

N/A

Manufactured by Bausch Health US, LLC

1,332 FDA adverse event reports analyzed

Last updated: 2026-04-15

About SELEGILINE HYDROCHLORIDE

SELEGILINE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Bausch Health US, LLC. The most commonly reported adverse reactions for SELEGILINE HYDROCHLORIDE include HALLUCINATION, FALL, DYSKINESIA, DRUG INEFFECTIVE, DRUG INTERACTION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for SELEGILINE HYDROCHLORIDE.

Top Adverse Reactions

HALLUCINATION61 reports
FALL47 reports
DYSKINESIA42 reports
DRUG INEFFECTIVE40 reports
DRUG INTERACTION37 reports
PARKINSON^S DISEASE31 reports
DEATH28 reports
HALLUCINATION, VISUAL28 reports
DIZZINESS27 reports
GAIT DISTURBANCE27 reports
TREMOR24 reports
NAUSEA23 reports
CONDITION AGGRAVATED22 reports
DELUSION22 reports
CONFUSIONAL STATE21 reports
INSOMNIA20 reports
CONSTIPATION19 reports
DEPRESSION19 reports
PYREXIA19 reports
SOMNOLENCE19 reports
ANXIETY18 reports
AGITATION17 reports
DECREASED APPETITE17 reports
DEHYDRATION17 reports
PNEUMONIA17 reports
DELIRIUM16 reports
FEELING ABNORMAL16 reports
BALANCE DISORDER15 reports
DYSPNOEA15 reports
HYPOTENSION15 reports
LOSS OF CONSCIOUSNESS15 reports
ASTHENIA14 reports
FATIGUE14 reports
HYPERHIDROSIS14 reports
PNEUMONIA ASPIRATION13 reports
PRODUCT DOSE OMISSION ISSUE13 reports
HYPERTENSION11 reports
MUSCLE RIGIDITY11 reports
OFF LABEL USE11 reports
PAIN11 reports
PARANOIA11 reports
SPEECH DISORDER11 reports
ANAEMIA10 reports
BLOOD CREATINE PHOSPHOKINASE INCREASED10 reports
BRADYCARDIA10 reports
BRADYKINESIA10 reports
DEPRESSED LEVEL OF CONSCIOUSNESS10 reports
MALAISE10 reports
MUSCULOSKELETAL STIFFNESS10 reports
URINARY TRACT INFECTION10 reports
ATRIAL FIBRILLATION9 reports
CARDIAC FAILURE9 reports
ORTHOSTATIC HYPOTENSION9 reports
PARKINSON'S DISEASE9 reports
RESTLESSNESS9 reports
SEROTONIN SYNDROME9 reports
ACUTE KIDNEY INJURY8 reports
ALTERED STATE OF CONSCIOUSNESS8 reports
CHEST PAIN8 reports
DYSPHAGIA8 reports
HALLUCINATION, AUDITORY8 reports
MOBILITY DECREASED8 reports
ON AND OFF PHENOMENON8 reports
PRODUCT USE ISSUE8 reports
SUICIDAL IDEATION8 reports
SYNCOPE8 reports
VISUAL IMPAIRMENT8 reports
WEIGHT DECREASED8 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS8 reports
ACCIDENTAL OVERDOSE7 reports
AGGRESSION7 reports
BLOOD PRESSURE DECREASED7 reports
COGNITIVE DISORDER7 reports
DRUG WITHDRAWAL SYNDROME7 reports
HALLUCINATIONS, MIXED7 reports
HEADACHE7 reports
IMPULSE CONTROL DISORDER7 reports
INCORRECT DOSE ADMINISTERED7 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES7 reports
MOVEMENT DISORDER7 reports
MUSCULAR WEAKNESS7 reports
OEDEMA PERIPHERAL7 reports
OVERDOSE7 reports
PAIN IN EXTREMITY7 reports
POSTURE ABNORMAL7 reports
PSYCHOTIC DISORDER7 reports
RESPIRATORY FAILURE7 reports
VOMITING7 reports
WEIGHT INCREASED7 reports
ABNORMAL BEHAVIOUR6 reports
COUGH6 reports
DIARRHOEA6 reports
DYSPEPSIA6 reports
DYSTONIA6 reports
HYPERKINESIA6 reports
HYPOGLYCAEMIA6 reports
HYPOKINESIA6 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION6 reports
MENTAL DISORDER6 reports
NEUROLEPTIC MALIGNANT SYNDROME6 reports

Report Outcomes

Out of 558 classified reports for SELEGILINE HYDROCHLORIDE:

Serious 79.6%Non-Serious 20.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male273 (53.7%)
Female235 (46.3%)

Reports by Age

Age 7619 reports
Age 6918 reports
Age 7017 reports
Age 7717 reports
Age 7516 reports
Age 7315 reports
Age 6514 reports
Age 6614 reports
Age 6814 reports
Age 7213 reports
Age 7412 reports
Age 8012 reports
Age 8512 reports
Age 7811 reports
Age 8411 reports
Age 6010 reports
Age 8110 reports
Age 649 reports
Age 799 reports
Age 828 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with SELEGILINE HYDROCHLORIDE?

This profile reflects 1,332 FDA FAERS reports that mention SELEGILINE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for SELEGILINE HYDROCHLORIDE?

Frequently reported terms in FAERS include HALLUCINATION, FALL, DYSKINESIA, DRUG INEFFECTIVE, DRUG INTERACTION, PARKINSON^S DISEASE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures SELEGILINE HYDROCHLORIDE?

Labeling and FAERS entries often list Bausch Health US, LLC in connection with SELEGILINE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.